These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 136763)

  • 81. [Management of anticancer drug adverse reactions].
    Akazawa S; Yamashina T; Konuma Y; Takahashi M; Ueno A
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():409-14. PubMed ID: 11424416
    [No Abstract]   [Full Text] [Related]  

  • 82. [Damage due to treatment of psoriasis with folic acid antagonists].
    Randazzo SD; Chiarenza A; Lazzaro C
    G Ital Dermatol Minerva Dermatol; 1972 Feb; 47(2):77-81. PubMed ID: 4260377
    [No Abstract]   [Full Text] [Related]  

  • 83. [Side-effects of phenylbutazone].
    Boixet EB
    Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):44-55. PubMed ID: 5998010
    [No Abstract]   [Full Text] [Related]  

  • 84. Adverse effects resulting from nitrofurantoin administration.
    Delaney RA; Miller DA; Gerbino PP
    Am J Pharm Sci Support Public Health; 1977; 149(1):26-8. PubMed ID: 141888
    [No Abstract]   [Full Text] [Related]  

  • 85. [Life threatening pleuropulmonary reaction as a drug side effect].
    Lang KF; Brodersen HC; Bose E; Schuster HP; Just HG
    Med Welt; 1971 Mar; 13():517-20. PubMed ID: 5563476
    [No Abstract]   [Full Text] [Related]  

  • 86. [On the toxic side-effects of antitubercular agents].
    Fossati C
    Clin Ter; 1972 Apr; 61(2):143-68. PubMed ID: 4556015
    [No Abstract]   [Full Text] [Related]  

  • 87. [Liver damage due to phenylbutazone and chlorpropamide].
    Grottum KA
    Tidsskr Nor Laegeforen; 1966 Aug; 86(16):1096-8. PubMed ID: 5919203
    [No Abstract]   [Full Text] [Related]  

  • 88. Sarcoid granulomas associated with phenylbutazone treatment.
    Lebacq EG; Desmet V
    Mt Sinai J Med; 1977; 44(6):778-81. PubMed ID: 145540
    [No Abstract]   [Full Text] [Related]  

  • 89. [Anti-retroviral treatment. Treatment modification: toxicity management].
    Ocaña I; Laguna F; Pulido F; Bascuñana A
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():31-5. PubMed ID: 9053025
    [No Abstract]   [Full Text] [Related]  

  • 90. Multi-organ disease secondary to sulfonamide toxicity.
    Pickert CB; Belsha CW; Kearns GL
    Pediatrics; 1994 Aug; 94(2 Pt 1):237-9. PubMed ID: 8036081
    [No Abstract]   [Full Text] [Related]  

  • 91. Adverse effects of antimicrobial agents on major organ systems.
    VanOmmen RA
    Cleve Clin Q; 1970 Jan; 37(1):59-71. PubMed ID: 4906261
    [No Abstract]   [Full Text] [Related]  

  • 92. [The rise in iatrogenic pathology].
    Lamotte M
    Rev Prat; 1974 Nov; 24(51):4393-7. PubMed ID: 4445770
    [No Abstract]   [Full Text] [Related]  

  • 93. Aspects of the safety of medicines.
    Harris EL
    Rheumatol Phys Med; 1972 Nov; 11(8):431-5. PubMed ID: 4646492
    [No Abstract]   [Full Text] [Related]  

  • 94. Allergic contact dermatitis from oxyphenbutazone.
    Pigatto PD; Riboldi A; Morelli M; Altomare GF; Polenghi MM
    Contact Dermatitis; 1985 Apr; 12(4):236-7. PubMed ID: 3160537
    [No Abstract]   [Full Text] [Related]  

  • 95. Acute oral toxicity of 4-dimethylaminophenol to the gastrointestinal tract, liver and kidney of the rat.
    Marrs TC; Bright JE; Swanston DW
    Arch Toxicol; 1982 May; 50(1):89-92. PubMed ID: 7115083
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Fixed eruption due to two unrelated drugs: oxyphenbutazone and tetracycline.
    Bhargava NC; Singh G
    Int J Dermatol; 1981; 20(6):435. PubMed ID: 6455387
    [No Abstract]   [Full Text] [Related]  

  • 97. Severe and life-threatening adverse reactions to psychotropic drugs.
    Spiess-Kiefer C; Grohmann R; Schmidt LG; Rüther E
    Pharmacopsychiatry; 1988 Nov; 21(6):290-2. PubMed ID: 3244756
    [No Abstract]   [Full Text] [Related]  

  • 98. Butazones under fire.
    Herxheimer A; Collier J; Rawlins MD; Schönhöfer P; Medawar C; Melrose D; Bannenberg W; Beardshaw V
    Lancet; 1985 Mar; 1(8428):580. PubMed ID: 2857928
    [No Abstract]   [Full Text] [Related]  

  • 99. [Multiple manifestations of intolerance in association with anti-inflammatory agents. Role of phenylbutazone].
    Tolot F; Prost G; Guignot B; Pelletier M
    Sem Hop Ther; 1976 Mar; 52(3):185-90. PubMed ID: 795032
    [No Abstract]   [Full Text] [Related]  

  • 100. Adverse reactions to cytostatic agents.
    Irey NS
    Recent Results Cancer Res; 1975; (52):36-41. PubMed ID: 1235003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.